| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.091 | 0.06 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.084 | 0.1 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.071 | 0.2 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.064 | 0.2 |